Efficacy of Switch to Lopinavir/Ritonavir in Improving Cognitive function in Efavirenz treated patients.

Trial Profile

Efficacy of Switch to Lopinavir/Ritonavir in Improving Cognitive function in Efavirenz treated patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Mar 2017

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Efavirenz
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms SLICE
  • Most Recent Events

    • 21 May 2015 Status changed from completed to active, recruiting as per ISRCTN record.
    • 31 Mar 2015 Status changed from active, no longer recruiting to completed, according to ISRCTN: Current Controlled Trials
    • 13 Nov 2014 Status changed from recruiting to active, no longer recruiting. as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top